Compliance and Risk Management Based on High Ethical Standards
First written in FY2016. 4 of 6 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2024: 4 of 23 companies on the "Worse" side.
16 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Revision of the Kissei Pharmaceutical Code of Practice」
The revision of the Code of Practice was included among the matters deliberated by the Board of Directors in fiscal 2025, and practices concerning compliance and the provision of information were reviewed. - FY2024RestatedAnnual report
「We have established the Risk Management Committee and the Compliance Committee as advisory bodies to the Board of Directors, set out the basic policy and management framework for company-wide risk management in the Risk Management Regulations, and have the Risk Management Committee develop a management framework to prevent risks that could arise at the company and its group companies and monitor progress.」
The company is reaffirming its management policies and practices under the Risk Management Regulations through the Risk Management Committee and the Compliance Committee. - FY2019RestatedAnnual report
「In order to comply with all laws, regulations, and their underlying principles, we have established the Compliance Committee as an advisory body to the Board of Directors and implemented a Compliance Program, including the preparation and revision of the Compliance Program Manual, which sets out practical guidelines, as well as ongoing education and training.」
The company is reaffirming its policy of compliance with laws and regulations through the Compliance Committee, programs, manuals, and education and training. - FY2018RestatedAnnual report
「In order to comply with all laws, regulations, and their underlying principles, we have established the Compliance Committee as an advisory body to the Board of Directors and implemented a Compliance Program, including the preparation and revision of the Compliance Program Manual, which sets out practical guidelines, as well as ongoing education and training.」
The company is reaffirming its policy and practices for compliance with laws and regulations through the Compliance Committee, programs, manuals, and education and training. - FY2017RestatedAnnual report
「To comply with all laws, regulations and their underlying principles, we have established a Compliance Committee as an advisory body to the Board of Directors, and operate a Compliance Program, including the preparation and revision of the Compliance Program Manual, which provides practical guidance, as well as ongoing education and training.」
The company is reaffirming its policy of high ethical standards and compliance with laws and regulations through the Compliance Committee, programs, manuals, and education and training. - FY2016First statedAnnual report
「As a life sciences company that researches, develops, manufactures and sells prescription pharmaceuticals, we conduct our activities at all times on the basis of high ethical standards, which form the foundation of our management. In addition, to comply with all laws, regulations and their underlying principles, we have established a Compliance Committee as an advisory body to the Board of Directors, and operate a Compliance Program, including the preparation and revision of the Compliance Program Manual, which provides practical guidance, as well as ongoing education and training.」
The company described a management structure based on the Compliance Committee, education and training, its basic internal control policy and the Risk Management Committee.